In these unprecedented times D4D are taking patient and staff safety very seriously.
Our priority has always been to develop technologies for patient benefit. Many of our collaborators are in high risk categories for Covid 19 infection, or are clinical staff providing front line care. We hope everyone is taking all the steps that are possible to keep themselves safe and maintain their physical and mental health; this may prove especially difficult for people living with multiple long-term conditions.
In light of the situation our Core Team have moved to home working; we remain active and can be contacted through the normal routes. As is expected at times like these some of our energies are currently being redirected to where they can be most beneficial, including through direct delivery or management of clinical services, support for services, or in developing technologies or resources for people at risk from or recovering from Covid 19. Several of our active projects and clinical trials have been paused either to protect our patient collaborators or to take pressure off our clinical colleagues. Whilst we are still receiving and discussing new collaboration or project requests our response times are likely to be slower than normal, and we may need to restrict the number of new projects that we commit to over the following months. Rest assured that we are more committed than ever to developing the highest priority technologies for situations where we have expertise.
We wish everyone the best at these difficult times, and hope you are all able to stay safe and well.